Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
A study to determine whether a new formulation of methylprednisolone suspension is bioequivalent to methylprednisolone tablets.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| methylprednisolone suspension | Experimental |
| |
| methylprednisolone tablets | Active Comparator |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| methylprednisolone | Drug | constituted powder for oral suspension 4 mg/mL single dose at 32 mg |
|
| Measure | Description | Time Frame |
|---|---|---|
| AUCinf (area under the concentration curve to infinity) | 0, 0.5, 1, 2, 3, 4, 5, 6, 10, 12, 16, 24 hours post dose | |
| Cmax (maximum concentration) | 0, 0.5, 1, 2, 3, 4, 5, 6, 10, 12, 16, 24 hours post dose |
| Measure | Description | Time Frame |
|---|---|---|
| AUC last (area under the concentration curve to last time point) | 0, 0.5, 1, 2, 3, 4, 5, 6, 10, 12, 16, 24 hours post dose | |
| Tmax (time at maximum concentration) | 0, 0.5, 1, 2, 3, 4, 5, 6, 10, 12, 16, 24 hours post dose |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Pfizer CT.gov Call Center | Pfizer | Study Director |
Not provided
Not provided
| Label | URL |
|---|---|
| To obtain contact information for a study center near you, click here. | View source |
Not provided
| ID | Term |
|---|---|
| D008775 | Methylprednisolone |
| ID | Term |
|---|---|
| D011239 | Prednisolone |
| D011246 | Pregnadienetriols |
| D011245 | Pregnadienes |
| D011278 | Pregnanes |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| methylprednisolone | Drug | tablets 32 mg single dose |
|
| Half-life | 0, 0.5, 1, 2, 3, 4, 5, 6, 10, 12, 16, 24 hours post dose |
| D013256 |
| Steroids |
| D000072473 | Fused-Ring Compounds |
| D011083 | Polycyclic Compounds |